Cancer‐associated fibroblasts: Key players in shaping the tumor immune microenvironment
M Desbois, Y Wang - Immunological reviews, 2021 - Wiley Online Library
Cancer immunotherapies have rapidly changed the therapeutic landscape for cancer.
Nevertheless, most of the patients show innate or acquired resistance to these therapies …
Nevertheless, most of the patients show innate or acquired resistance to these therapies …
Cancer-associated fibroblasts: Key players in shaping the tumor immune microenvironment
M Desbois, Y Wang - Immunological reviews, 2021 - pubmed.ncbi.nlm.nih.gov
Cancer immunotherapies have rapidly changed the therapeutic landscape for cancer.
Nevertheless, most of the patients show innate or acquired resistance to these therapies …
Nevertheless, most of the patients show innate or acquired resistance to these therapies …
Cancer-associated fibroblasts: Key players in shaping the tumor immune microenvironment.
M Desbois, Y Wang - Immunological Reviews, 2021 - europepmc.org
Cancer immunotherapies have rapidly changed the therapeutic landscape for cancer.
Nevertheless, most of the patients show innate or acquired resistance to these therapies …
Nevertheless, most of the patients show innate or acquired resistance to these therapies …
Cancer‐associated fibroblasts: Key players in shaping the tumor immune microenvironment.
M Desbois, Y Wang - Immunological Reviews, 2021 - search.ebscohost.com
Cancer immunotherapies have rapidly changed the therapeutic landscape for cancer.
Nevertheless, most of the patients show innate or acquired resistance to these therapies …
Nevertheless, most of the patients show innate or acquired resistance to these therapies …